Cargando…
Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of Pancreatic Cancer
Pancreatic cancer is a significant cause of cancer-related deaths in the United States with an abysmal five-year overall survival rate that is under 9%. Reasons for this mortality include the lack of late-stage treatment options and the immunosuppressive tumor microenvironment. Histotripsy is an ult...
Autores principales: | Hendricks-Wenger, Alissa, Sereno, Jacqueline, Gannon, Jessica, Zeher, Allison, Brock, Rebecca M., Beitel-White, Natalie, Simon, Alexander, Davalos, Rafael V., Coutermarsh-Ott, Sheryl, Vlaisavljevich, Eli, Allen, Irving Coy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295194/ https://www.ncbi.nlm.nih.gov/pubmed/33956631 http://dx.doi.org/10.1109/TUFFC.2021.3078094 |
Ejemplares similares
-
Ablative and Immunostimulatory Effects of Histotripsy Ablation in a Murine Osteosarcoma Model
por: Hay, Alayna N., et al.
Publicado: (2023) -
Immunological Effects of Histotripsy for Cancer Therapy
por: Hendricks-Wenger, Alissa, et al.
Publicado: (2021) -
Histotripsy for the Treatment of Cholangiocarcinoma Liver Tumors: In Vivo Feasibility and Ex Vivo Dosimetry Study
por: Hendricks-Wenger, Alissa, et al.
Publicado: (2021) -
Histotripsy ablation for the treatment of feline injection site sarcomas: a first-in-cat in vivo feasibility study
por: Ruger, Lauren, et al.
Publicado: (2023) -
Histotripsy Ablation in Preclinical Animal Models of Cancer and Spontaneous Tumors in Veterinary Patients: A Review
por: Hendricks-Wenger, Alissa, et al.
Publicado: (2022)